Posted by Frank (18.104.22.168) on September 26, 2000 at 11:24:48:
I ran across an article "Changes in Resource Use and Outcomes for Patients With Migraine Treated With Sumatriptan: A Managed Care Perspective" (Arch Intern Med — April 26, 1999). http://www.ama-assn.org/special/migraine/library/readroom/oi80324.htm
In summary, it concludes that although Imitrex is expensive for insurance companies, it is cheap in the long run...
Post a Followup